Literature DB >> 3859133

Mass cytologic screening for cervical carcinoma in China. A review of 7,735,057 reported cases.

D W Yang, J F Yao, S F Xing, Y X Lin.   

Abstract

A review was made of cervical carcinoma screening in 7,735,057 cases based on 140 reports from 25 provinces and autonomous regions in the People's Republic of China. The average prevalence rate of carcinoma of the cervix was 138.74/10(5); the rate was higher in the mountainous districts, and was related to the early age of marriage, the number of children delivered and the existence of cervical lesions. Proper preventive measures imposed by the government, early detection and early treatment have brought about a marked decline of the prevalence and mortality rates. The repeated mass cytologic screenings have made radical cure of this disease possible. Concurrent geographic clustering of carcinomas of both the cervix and penis have been noted, and screening of spouses has been started.

Entities:  

Mesh:

Year:  1985        PMID: 3859133

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  4 in total

1.  Effect of radiotherapy on oral mucosa assessed by quantitative exfoliative cytology.

Authors:  G R Ogden; J G Cowpe; M W Green
Journal:  J Clin Pathol       Date:  1989-09       Impact factor: 3.411

2.  Quantitative assessment of various fixatives on nuclear and cytoplasmic areas in oral cytology.

Authors:  G R Ogden; M W Green; J G Cowpe
Journal:  Histochem J       Date:  1989-12

3.  In situ hybridization analysis of HPV DNA in cervical precancer and cervical cancers from China.

Authors:  H X Ji; S Syrjänen; K Syrjänen; A R Wu; F J Chang
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

4.  Trends in geographical disparities for cervical cancer mortality in China from 1973 to 2013: a subnational spatio-temporal study.

Authors:  Changfa Xia; Chao Ding; Rongshou Zheng; Siwei Zhang; Hongmei Zeng; Jinfeng Wang; Yilan Liao; Ningxu Zhang; Zhixun Yang; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2017-12       Impact factor: 5.087

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.